Regression results of mechanism analysis. by Qi Zhang (28502)

Subjects:

Descriptive statistical results. by Qi Zhang (28502)

Subjects:

Financing environment and regional heterogeneity regression results. by Qi Zhang (28502)

Subjects:

Instrumental variable regression results. by Qi Zhang (28502)

Subjects:

Volitional control frequency and intensity in VH (Kapsner-Smith et al., 2025) by Mara R. Kapsner-Smith (22139315)

“…Group differences were tested with general linear models.</p><p dir="ltr"><b>Results: </b>No significant differences were found between people with and without HVDs on any of the measures. …”

Correlation test. by Tiantian Dong (6247917)

“…The findings indicate that consumption inequality has a significant negative impact on SWB. Specifically, for every unit increase in consumption inequality, the probability of individuals rating their SWB as “Happy” and “Very happy” decreases by 0.37% and 5.45% respectively. …”

Robustness test. by Tiantian Dong (6247917)

“…The findings indicate that consumption inequality has a significant negative impact on SWB. Specifically, for every unit increase in consumption inequality, the probability of individuals rating their SWB as “Happy” and “Very happy” decreases by 0.37% and 5.45% respectively. …”

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and adju... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and simple steatosis (SS) groups, and adjusted p-values. by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the normal liver (NL) and metabolic dysfunction-associated steatotic liver disease (MASLD) groups,... by Laia Bertran (3685147)

Log2 fold change (FC), mean and standard deviation (SD) of each lipid specie from the simple steatosis (SS) and metabolic dysfunction-associated steatohepatitis (MASH) groups, and... by Laia Bertran (3685147)

Impact of sludge dosage on HPST. by Peng Zhao (128233)

Subjects:

Impact of settling time on HPST. by Peng Zhao (128233)

Subjects:

ANOVAs for the response surface of Eq (2). by Peng Zhao (128233)

Subjects:

Impact of CPAM dosage on HPST. by Peng Zhao (128233)

Subjects:

Impact of sewage pH on HPST. by Peng Zhao (128233)

Subjects:

Impact of PAC dosage on HPST. by Peng Zhao (128233)

Subjects:

Training impact on electrical properties of P3 lumbar MNs. Rin: input resistance. Rheobase: lowest intensity of current injected in MNs to elicit an action potential (AP). AP threshold: voltage measured at the foot of the AP. AP amplitude: measured between the resting membrane potential and the AP peak. AP half width: time spent by the potential > 50% of the AP maximum amplitude. AP rise time: time spent by the potential between 10% and 90% of the AP maximum amplitude. AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential. All values are means ± SEM. The number of MNs recorded is indicated between brackets. ns: no significantly different. P-values are obtained from Mann-Whitney test or T-test statistical analysis, depending of the normal distribution of data sets.... by Camille Quilgars (21156495)

“…The number of MNs recorded is indicated between brackets. ns: no significantly different. P-values are obtained from Mann-Whitney test or T-test statistical analysis, depending of the normal distribution of data sets. …”

<b> </b> Spatial memory assessment in Morris water maze test. 5A: Effect of different treatments on time spent in the target zone. Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01).... by Atefeh Sadeghi (21253051)

“…Alcl3 significantly decreased the time spent in the target zone with respect to the saline-treated group (p < 0.01). …”

Supplementary Material for: Adjunctive active vitamin D (AVD) decreases kidney function during treatment of secondary hyperparathyroidism (SHPT) with extended-release calcifediol (... by figshare admin karger (2628495)